Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Tablets in Non-diabetic Overweight or Obese Adult Subjects

NCT07166081 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-diabetic Overweight or Obese

Interventions

DRUG: BGM0504
DRUG: BGM0504
DRUG: BGM0504
DRUG: Placebo
DRUG: BGM0504

Sponsor

BrightGene Bio-Medical Technology Co., Ltd.